Logo image of PRXL

PAREXEL INTL CORP (PRXL) Stock Price, Quote, News and Overview

NASDAQ:PRXL - Nasdaq - US6994621075

88.08  -0.02 (-0.02%)

After market: 88.08 0 (0%)

PRXL Quote, Performance and Key Statistics

PAREXEL INTL CORP

NASDAQ:PRXL (9/29/2017, 8:10:00 PM)

After market: 88.08 0 (0%)

88.08

-0.02 (-0.02%)

Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
Statistics
52 Week High88.1
52 Week Low51.16
Market Cap4.50B
Shares51.12M
FloatN/A
Yearly Dividend0
Dividend Yield0%
PE42.76
Fwd PE22.94
Earnings (Next)N/A N/A
IPON/A N/A


PRXL short term performance overview.The bars show the price performance of PRXL in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30

PRXL long term performance overview.The bars show the price performance of PRXL in the last 1, 2 and 3 years. 1 year 2 years 3 years 5 10 15 20 25

The current stock price of PRXL is 88.08 null. In the past month the price increased by 0.22%. In the past year, price increased by 26.83%.

PAREXEL INTL CORP / PRXL Daily stock chart

About PRXL

Company Profile

Parexel International Corporation is one of the largest biopharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. With a commitment to providing solutions that expedite time-to-market and peak market penetration, PAREXEL has developed significant expertise in clinical trials management, data management, biostatistical analysis, medical marketing, clinical pharmacology, regulatory and medical consulting, industry training and publishing and other drug development consulting services. Its information technology subsidiary, Perceptive Informatics, Inc., develops and offers a portfolio of innovative technology-based products and services that facilitate clinical drug development and are designed to decrease time to peak sales.

Company Info

PAREXEL INTL CORP

195 WEST ST

WALTHAM MA 02451

CEO: Josef H. von Rickenbach

Phone: 781-487-9900

PAREXEL INTL CORP / PRXL FAQ

What is the stock price of PAREXEL INTL CORP today?

The current stock price of PRXL is 88.08 null. The price decreased by -0.02% in the last trading session.


What is the ticker symbol for PAREXEL INTL CORP stock?

The exchange symbol of PAREXEL INTL CORP is PRXL and it is listed on the Nasdaq exchange.


On which exchange is PRXL stock listed?

PRXL stock is listed on the Nasdaq exchange.


What is PAREXEL INTL CORP worth?

PAREXEL INTL CORP (PRXL) has a market capitalization of 4.50B null. This makes PRXL a Mid Cap stock.


What are the support and resistance levels for PAREXEL INTL CORP (PRXL) stock?

PAREXEL INTL CORP (PRXL) has a support level at 88.03 and a resistance level at 88.09. Check the full technical report for a detailed analysis of PRXL support and resistance levels.


Should I buy PAREXEL INTL CORP (PRXL) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does PAREXEL INTL CORP (PRXL) stock pay dividends?

PRXL does not pay a dividend.


What is the Price/Earnings (PE) ratio of PAREXEL INTL CORP (PRXL)?

The PE ratio for PAREXEL INTL CORP (PRXL) is 42.76. This is based on the reported non-GAAP earnings per share of 2.06 and the current share price of 88.08 null. Check the full fundamental report for a full analysis of the valuation metrics for PRXL.


PRXL Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to PRXL. When comparing the yearly performance of all stocks, PRXL is one of the better performing stocks in the market, outperforming 76.56% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

PRXL Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to PRXL. Both the profitability and the financial health of PRXL get a neutral evaluation. Nothing too spectacular is happening here.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PRXL Financial Highlights

Over the last trailing twelve months PRXL reported a non-GAAP Earnings per Share(EPS) of 2.06. The EPS decreased by -27.97% compared to the year before.


Industry RankSector Rank
PM (TTM) 4.39%
ROA 4.64%
ROE 16.91%
Debt/Equity 1.01
Chartmill High Growth Momentum
EPS Q2Q%-24.05%
Sales Q2Q%3.53%
EPS 1Y (TTM)-27.97%
Revenue 1Y (TTM)0.63%

PRXL Ownership and Analysts


Ownership
Inst Owners87.45%
Ins Owners0.57%
Short Float %N/A
Short RatioN/A
Analysts
AnalystsN/A
Price TargetN/A
EPS Next Y86.41%
Revenue Next YearN/A